Nadav Kidron is President, Chief Executive Officer and Chairman of Oramed Pharmaceuticals Inc. (ORMP). The company reported total compensation of $4,774,660 for fiscal year 2025.
| Salary | $619,529 |
|---|---|
| Bonus | $379,935 |
| Stock awards | $3,709,269 |
| Option awards | $0 |
| Non-equity incentive plan | — |
| Pension and non-qualified deferred compensation | — |
| All other compensation | $65,927 |
| Total | $4,774,660 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Oramed Pharmaceuticals Inc. filed August 3, 2026, accession 0001213900-26-084609.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Nadav Kidron this page | President, Chief Executive Officer and Chairman | $4,774,660 |
| Joshua Hexter | Chief Operating and Business Officer | $1,882,398 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Oramed Pharmaceuticals Inc. compensation brief.
Nadav Kidron's compensation sits inside Oramed Pharmaceuticals Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.